Novel trastuzumab duocarmazine significantly improved survival in advanced HER2-positive breast cancerSeptember 30, 2021Breast CancerMetastatic Breast Cancer
Treatment shows 'important improvements' in triple-negative breast cancerSeptember 30, 2021Breast CancerMetastatic Breast Cancer
Better survival with extended letrozole in early-stage breast cancerSeptember 29, 2021Breast CancerMetastatic Breast Cancer
Evaluation of the Impact of the VHA National Precision Oncology Program (NPOP) on Prior Authorization Adjudication of Targeted Anti-Cancer AgentsSeptember 23, 2021
Improving the Efficiency of Ordering Next Generation Sequencing During New Patient Triage: A Quality Improvement ProjectSeptember 23, 2021
Successful Recruitment of VA Patients in Precision Medicine Research Through Passive Recruitment EffortsSeptember 23, 2021
Study supports add-on therapy for germline and wildtype BRCA mutationsSeptember 22, 2021Breast Cancer
Twelve-month overall survival benefit with ribociclib for metastatic breast cancerSeptember 21, 2021Breast CancerMetastatic Breast Cancer
